$ABEV · Ambev S.A. Congress Trades

Rep. Josh Gottheimer (NJ-05) executed extensive portfolio rebalancing in February 2025, with significant activity in major tech stocks including Microsoft call options ($1M-$5M purchases across multiple strike prices and expiration dates) and partial sales of Apple, Microsoft common stock, and numerous other holdings in the $1,001-$15,000 range each. Most trades occurred through Morgan Stanley managed accounts on dates between 02/03/2025-02/28/2025.

Rep. Josh Gottheimer (NJ-05) executed extensive trading activity in January 2025 through a Morgan Stanley managed account, with over 100 transactions involving purchases and sales across a diversified portfolio of blue-chip stocks, technology companies, and international equities. Most transactions ranged from $1,001-$15,000, with one notable sale of Merck & Company (MRK) in the $15,001-$50,000 range on January 27, 2025.

Rep. Josh Gottheimer (NJ-05) executed a diverse portfolio of transactions in December 2024, including significant options activity on Microsoft (MSFT) with multiple call option sales and purchases ranging from $1,000,001-$5,000,000, along with numerous stock purchases and sales across major companies including Apple, Goldman Sachs, Johnson & Johnson, Walmart, and Tesla, with most individual stock transactions in the $1,001-$15,000 range.

Rep. Josh Gottheimer (NJ-05) executed 73 stock transactions during July 2024 across a diversified portfolio managed through Morgan Stanley accounts, with transaction amounts ranging from $1,001-$15,000 each. The activity included purchases and partial sales of major tech stocks (Tesla, Meta, Netflix, Alphabet), financial services (Mastercard, Block), healthcare (Eli Lilly, Regeneron, AtriCure), industrial (Northrop Grumman, D.R. Horton), and international equities.